Tylenol maker Kenvue to cut 4% jobs, ... Kenvue's stock is down 11% so far this year, and 13% from its IPO price since listing in May last year. Shares were up 2.3% in premarket trading on Tuesday.
La plus grande entreprise de santé grand public au monde en termes de chiffre d’affaires a annoncé étendre ses lignes de production pour quatre produits : Reactive/Ziyrtec, Benadryl ...
Franck Riester, ministre délégué auprès du ministre de l’Europe et des Affaires étrangères, sera à Val-de-Reuil (Eure), mardi 14 mai 2024, pour visiter le site normand de l’entreprise ...
Le consensus des membres ABC Bourse est construit à l'aide des objectifs exprimés par les internautes. Vous pouvez donner votre opinion et la modifier à tout moment en redonnant un objectif. En savoir ...
, opens new tab will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first ...
Kenvue's skin health and beauty segment, consisting of brands including Neutrogena and Clean & Clear, recorded a 5% drop in first-quarter sales to $1.05 billion, but largely in line with estimates.
(Reuters) – Kenvue beat Wall Street estimates for first-quarter profit on Tuesday, and said it would cut 4% of its global workforce amid the Tylenol and Band-Aid maker’s efforts to expand its key ...